Search Results - "SZENDROI, Attila"

Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 cases by Szarvas, Tibor, Ph.D, Módos, Orsolya, M.D, Niedworok, Christian, M.D, Reis, Henning, M.D, Szendröi, Attila, M.D, Szász, Marcell A., M.D, Nyirády, Péter, M.D

“…Abstract Background and objectives Urachal carcinoma (UrC) is a rare and poorly investigated disease. Our current knowledge is mainly based on…”
Get full text

Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis by Niedworok, Christian, Panitz, Martin, Szarvas, Tibor, Reis, Henning, Reis, Anna Carinna, Szendröi, Attila, Nyirády, Peter, Szasz, A. Marcell, Módos, Orsolya, Rübben, Herbert, vom Dorp, Frank

“…Purpose Urachal carcinoma of the bladder is a rare malignancy. Its histological phenotype is similar to that of primary bladder and colorectal adenocarcinoma…”
Get full text

Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer by Krafft, Ulrich, Tschirdewahn, Stephan, Hess, Jochen, Harke, Nina N., Hadaschik, Boris, Olah, Csilla, Krege, Susanne, Nyirády, Peter, Szendröi, Attila, Szücs, Miklós, Módos, Orsolya, Székely, Eszter, Reis, Henning, Szarvas, Tibor

“…•HMGA2 immunostaining correlates with poor survival in chemo-treated BC patients.•Survivin is an independent predictor of cisplatin therapy in BC…”
Get full text

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance by Módos, Orsolya, Reis, Henning, Niedworok, Christian, Rübben, Herbert, Szendröi, Attila, Szász, Marcell A, Tímár, József, Baghy, Kornélia, Kovalszky, Ilona, Golabek, Tomasz, Chlosta, Piotr, Okon, Krzysztof, Peyronnet, Benoit, Mathieu, Romain, Shariat, Shahrokh F, Hollósi, Péter, Nyirády, Péter, Szarvas, Tibor

“…Targeted therapy represents an attractive alternative for rare tumors such as urachal carcinoma (UrC). The aim of this study was to assess the mutations of the…”
Get full text

Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols by Budai, Bettina Katalin, Stollmayer, Róbert, Rónaszéki, Aladár Dávid, Körmendy, Borbála, Zsombor, Zita, Palotás, Lõrinc, Fejér, Bence, Szendrõi, Attila, Székely, Eszter, Maurovich-Horvat, Pál, Kaposi, Pál Novák

“…Introduction This study aimed to construct a radiomics-based machine learning (ML) model for differentiation between non-clear cell and clear cell renal cell…”
Get full text

Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine by Szendrői, Miklós, Antal, Imre, Szendrői, Attila, Lazáry, Áron, Varga, Péter Pál

“…Oncological management of skeletal metastases has changed dramatically in the last few decades. A significant number of patients survive for many years with…”
Get full text

Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer by Szarvas, Tibor, László, Viktória, vom Dorp, Frank, Reis, Henning, Szendröi, Attila, Romics, Imre, Tilki, Derya, Rübben, Herbert, Ergün, Süleyman

“…Endostatin, the proteolytic fragment of collagen XVIII, is an inhibitor of angiogenesis and tumor growth. Interestingly, elevated circulating endostatin levels…”
Get full text

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients by Olah, Csilla, Tschirdewahn, Stephan, Hoffmann, Michèle J., Krafft, Ulrich, Hadaschik, Boris, Nyirady, Peter, Szendröi, Attila, Módos, Orsolya, Csizmarik, Anita, Kovalszky, Ilona, Reis, Henning, Szarvas, Tibor

“…Cisplatin-containing chemotherapy represents the first-line treatment for patients with locally advanced or metastatic muscle-invasive bladder cancer…”
Get full text

Gene network and canonical pathway analysis in prostate cancer: a microarray study by Savli, Hakan, Szendröi, Attila, Romics, Imre, Nagy, Balint

“…The molecular mechanism playing a role in the development of prostate cancer (PCA) is not well defined. We decided to determine the changes in gene expression…”
Get full text

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas by Varadi, Melinda, Nagy, Nikolett, Reis, Henning, Hadaschik, Boris, Niedworok, Christian, Modos, Orsolya, Szendroi, Attila, Ablat, Jason, Black, Peter C., Keresztes, David, Csizmarik, Anita, Olah, Csilla, Gaisa, Nadine T., Kiss, Andras, Timar, Jozsef, Toth, Erika, Csernak, Erzsebet, Gerstner, Arpad, Mittal, Vinay, Karkampouna, Sofia, Kruithof de Julio, Marianna, Gyorffy, Balazs, Bedics, Gabor, Rink, Michael, Fisch, Margit, Nyirady, Peter, Szarvas, Tibor

“…Objective Administration of targeted therapies provides a promising treatment strategy for urachal adenocarcinoma (UrC) or primary bladder adenocarcinoma…”
Get full text

β‐catenin expression and claudin expression pattern as prognostic factors of prostatic cancer progression by Szász, Attila M., Nyirády, Péter, Majoros, Attila, Szendrõi, Attila, Szûcs, Miklós, Székely, Eszter, Tõkés, Anna‐Mária, Romics, Imre, Kulka, Janina

“…OBJECTIVE To investigate the patterns of expression of the junctional proteins β‐catenin and claudins in different prognostic groups of patients with prostatic…”
Get full text

Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT by Bata, Pal, Gyebnar, Janos, Tarnoki, David Laszlo, Tarnoki, Adam Domonkos, Kekesi, Dora, Szendroi, Attila, Fejer, Bence, Szasz, A Marcell, Nyirady, Peter, Karlinger, Kinga, Berczi, Viktor

“…Conventional clear cell renal cell carcinoma (ccRCC) and papillary renal cell carcinoma (pRCC) have different behavioral characteristics and clinical…”
Get full text

Essentials for Standardising the Undergraduate Urology Curriculum in Europe: Outcomes of a Delphi Consensus from the European School of Urology by Gómez Rivas, Juan, Somani, Bhaskar, Rodriguez Socarrás, Moises, Marra, Giancarlo, Pearce, Ian, Henningsohn, Lars, Zondervan, Patricia, van der Poel, Henk, Van Poppel, Hendrik, N’Dow, James, Liatsikos, Evangelos, Palou, Joan, Stanisavljevic, Rade, Nebojsa, Bojanic, Banov, Pavel, Spivak, Leonid, Giannakopoulos, Stilianos, Álvarez-Maestro, Mario, Svihra, Jan, Page, Tobias, Yuruk, Emrah, Silva-Ramos, Miguel, Sarikaya, Saban, Porpiglia, Francesco, Szendroi, Attila

“…The burden of urological diseases is rising as the worldwide population ages. Although specialist urological provision is needed, a large proportion of these…”
Get full text

Identifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell lines by Pénzváltó, Zsófia, Tegze, Bálint, Szász, A Marcell, Sztupinszki, Zsófia, Likó, István, Szendrői, Attila, Schäfer, Reinhold, Győrffy, Balázs

“…Because of the low overall response rates of 10-47% to targeted cancer therapeutics, there is an increasing need for predictive biomarkers. We aimed to…”
Get full text

Less invasive treatment option for renal carcinoma with venous tumor thrombus by Nagy, Zoltán, Pánovics, József, Szendrői, Attila, Szász, Attila M, Harsányi, László, Romics, Imre

“…To retrospectively analyze patients treated by renal tumor and venous tumor thrombus (VVT) removal and to introduce a less stressful and safer surgical method…”
Get full text

Bosniak category III cysts are more likely to be malignant than we expected in the era of multidetector computed tomography technology by Bata, Pal, Tarnoki, Adam Domonkos, Tarnoki, David Laszlo, Szasz, Attila Marcell, Poloskei, Gergely, Fejer, Bence, Gyebnar, Janos, Nyirady, Peter, Berczi, Viktor, Karlinger, Kinga, Szendroi, Attila

“…Complex indeterminate Bosniak category III renal cystic masses are traditionally considered to be malignant in 50%. Our aim was to retrospectively evaluate the…”
Get full text

EGFR and VEGFR2 Protein Expressions in Bone Metastases of Clear Cell Renal Cancer by BADALIAN, Gayane, DERECSKEI, Katalin, SZENDROI, Attila, SZENDROI, Miklos, TIMAR, Jozsef

“…Background: EGFR and VEGFR2 protein expressions are hallmarks of clear cell renal cancer (RCC) with questionable prognostic impact. The skeletal system is one…”
Get full text

Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas by Reis, Henning, van der Vos, Kristan E., Niedworok, Christian, Herold, Thomas, Módos, Orsolya, Szendrői, Attila, Hager, Thomas, Ingenwerth, Marc, Vis, Daniël J., Behrendt, Mark A., de Jong, Jeroen, van der Heijden, Michiel S., Peyronnet, Benoit, Mathieu, Romain, Wiesweg, Marcel, Ablat, Jason, Okon, Krzysztof, Tolkach, Yuri, Keresztes, David, Nagy, Nikolett, Bremmer, Felix, Gaisa, Nadine T., Chlosta, Piotr, Kriegsmann, Joerg, Kovalszky, Ilona, Timar, József, Kristiansen, Glen, Radzun, Heinz‐Joachim, Knüchel, Ruth, Schuler, Martin, Black, Peter C., Rübben, Herbert, Hadaschik, Boris A., Schmid, Kurt Werner, van Rhijn, Bas W.G., Nyirády, Péter, Szarvas, Tibor

“…Urachal cancer (UrC) is a rare but aggressive malignancy often diagnosed in advanced stages requiring systemic treatment. Although cytotoxic chemotherapy is of…”
Get full text

Detection of bladder cancer from the urine using fluorescence in situ hybridization technique by Riesz, Péter, Lotz, Gábor, Páska, Csilla, Szendrôi, Attila, Majoros, Attila, Németh, Zsuzsanna, Törzsök, Péter, Szarvas, Tibor, Kovalszky, Ilona, Schaff, Zsuzsa, Romics, Imre, Kiss, András

“…The authors report on their first experiences with the UroVysion fluorescence in situ hybridization (FISH) kit developed for the detection of bladder cancer…”
Get full text

Prevalence of APC and PTEN Alterations in Urachal Cancer by Nagy, Nikolett, Reis, Henning, Hadaschik, Boris, Niedworok, Christian, Módos, Orsolya, Szendrői, Attila, Bíró, Krisztina, Hager, Thomas, Herold, Thomas, Ablat, Jason, Black, Peter C., Okon, Krzysztof, Tolkach, Yuri, Csizmarik, Anita, Oláh, Csilla, Keresztes, David, Bremmer, Felix, Gaisa, Nadine T., Kriegsmann, Joerg, Kovalszky, Ilona, Kiss, András, Tímár, József, Szász, Marcell A., Rink, Michael, Fisch, Margit, Nyirády, Péter, Szarvas, Tibor

“…Urachal carcinoma (UrC) is a rare tumor with remarkable histological and molecular similarities to colorectal cancer (CRC). Adenomatous polyposis coli ( APC)…”
Get full text